bullish
Shekel Brainweigh Ltd - Aiming for EBITDA Breakeven in Q4 CY23
SUMMARY
- Shekel Brainweigh Limited (ASX:SBW) reported FY22 sales growth of 14% to US$26.3m, which included 117% growth in Retail Innovation sales to $US2.0m.
- Revenue growth has continued into Q1 FY23 with 13% underlying growth, driven by 32% growth in the Self-Checkout division.
- We estimate an adjusted FY22 EBITDA loss (before amortisation, one-off costs and share-based payments) of US$3.3m, in-line with CY21 and impacted by a ~530bps decline in gross margin, predominantly in H2 FY22.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Research as a Service (RaaS)
Insightful Financial Models and Research Analysis
Price Chart(Sign Up to Access)
- Shekel Brainweigh Ltd - Aiming for EBITDA Breakeven in Q4 CY2301 May 2023
x